Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

712
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
712
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

3.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

sweelin®, a novel sweet protein, does not affect blood glucose and insulin levels - a double-blind, crossover, randomized study.

Food chemistry·2026
Same author

Variability in muscle function deficits and clinical identification of sarcopenic obesity in older adults with type 2 diabetes.

Frontiers in medicine·2026
Same author

Hot flashes linked to linguistic markers of cognitive impairment: observational study of social media posts.

Menopause (New York, N.Y.)·2025
Same author

Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611.

Diabetes care·2025
Same author

OSA in Women: Associations With Reproductive Aging and Screening Challenges.

Chest·2025
Same author

Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen.

Diabetes care·2025
Same journal

Retinol, Carotenoid, and Tocopherol Intake and Status, and the Risk of Islet Autoimmunity and Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study.

Diabetes/metabolism research and reviews·2026
Same journal

Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early-Onset Type 2 Diabetes Mellitus.

Diabetes/metabolism research and reviews·2026
Same journal

Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis.

Diabetes/metabolism research and reviews·2026
Same journal

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Diabetes/metabolism research and reviews·2026
Same journal

Associations of GA and GMI/GA Ratio With All-Cause Mortality in Well-Controlled Type 2 Diabetes Defined by Continuous Glucose Monitoring.

Diabetes/metabolism research and reviews·2026
Same journal

Diabetic Foot Ulceration in Dialysis-Dependent End-Stage Kidney Disease: A Systematic Review of Epidemiology, Clinical Outcomes and Mortality Risk.

Diabetes/metabolism research and reviews·2026
See all related articles

Related Experiment Video

Updated: Dec 20, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Improving blood glucose level predictability using machine learning.

Yonit Marcus1,2, Roy Eldor1,2, Mariana Yaron1,2

  • 1The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.

Diabetes/Metabolism Research and Reviews
|May 24, 2020
PubMed
Summary
This summary is machine-generated.

This study uses patient-specific machine learning to predict blood glucose levels and alert type-1 diabetes patients to future hypoglycemia and hyperglycemia events, improving glycemic control.

Keywords:
blood glucose predictabilitysupervised machine learningtype-1 diabetes

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.3K

Related Experiment Videos

Last Updated: Dec 20, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.3K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Type-1 diabetes management requires continuous glucose monitoring and accurate prediction of glycemic events.
  • Existing methods for predicting hypoglycemia and hyperglycemia often have high false-positive rates.
  • Personalized approaches are needed to improve the accuracy of glucose level predictions.

Purpose of the Study:

  • To develop and validate a patient-specific supervised-machine-learning (SML) algorithm for predicting blood glucose levels.
  • To improve the accuracy of future hypoglycemic and hyperglycemic event alerts using continuous-glucose-monitoring (CGM) data.
  • To minimize false-positive alerts in glucose level predictions for type-1 diabetes patients.

Main Methods:

  • Analysis of CGM data from 11 type-1 diabetic patients (aged 18-39) over 7-50 non-consecutive days.
  • Application of four SML models, with an algorithm selecting the best-fit model for each patient.
  • Calculation of statistical parameters to assess prediction errors, including root-mean-square-error and absolute-mean-error.

Main Results:

  • The SML algorithm accurately predicted glucose levels 30 minutes ahead, with an average root-mean-square-error of 20.48 mg/dL and average absolute-mean-error of 15.36 mg/dL.
  • Achieved a true-positive hypoglycemia prediction rate of 64% with a low false-positive rate of 4.0% and false-negative rate of 0.015%.
  • True-positive hyperglycemia prediction rate was 61%, demonstrating the algorithm's effectiveness in detecting both hypo- and hyperglycemia.

Conclusions:

  • Patient-specific SML analysis of CGM data is effective for predicting glucose levels and alerting type-1 diabetes patients to glycemic events.
  • The developed algorithm can enhance glycemic control, improve basal and bolus insulin calculations, and is suitable for artificial pancreas systems.
  • This personalized medical solution identifies the optimal prediction method for individual patients, offering a significant advancement in diabetes management.